Akebia Therapeutics, Inc. ($AKBA)
Filing Information
| Accession Number | 0001661887-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
84,829
Total Value
$117,912.31
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 53,585 | $1.39 | $74,483.15 | 592,994 | Direct | โ | View Details | |
Chief Commercial Officer | Common Stock | โ | Feb 2, 2026 | Sale | 31,244 | $1.39 | $43,429.16 | 561,750 | Direct | โ | View Details |